Ochner CN, Gibson C, Shanik M, Goel V, Geliebter A
The buzz surrounding GLP-1s keeps getting louder, and for good reason: The medications are highly effective at treating type 2 diabetes and obesity , and are also linked to improved blood pressure and protection against heart disease
Clinical Evidence: What the Research Shows While Retatrutide-specific addiction research remains in early stages, substantial evidence from studies on related GLP-1 medications provides strong rationale for investigating its potential in alcohol use disorder
Semaglutide 2.4 mg (Wegovy) is approved under NICE technology appraisal TA875, and tirzepatide (Mounjaro) has also received a NICE technology appraisal for weight management
Back Bell, GI, Sangez-Pescador, R, Laybourn, PJ, Najarian RC (1983) 'Exon duplication and divergence in the human preproglucagon gene', Nature , 304, 368-71
Shirt collars fit differently